PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ardisicreolide C and Ardisicreolides A-B demonstrated anti-inflammatory activity in vitro using LPS-induced RAW 264.7 macrophage cells [PMID:38108118, PMID:35956852]
Ardicrenin showed significant cytotoxicity against A549, MCF-7, HepG2, and MDA-MB-231 cells [PMID:33516453] and suppressed MG-63 osteosarcoma cell proliferation [PMID:41577017]. Root extracts showed potency against melanoma WM793 and colon cancer Caco2 [PMID:34089236]. Rapanone exhibited cytotoxic activity toward prostate cancer, thyroid cancer, and colorectal carcinoma cell lines [PMID:36432013].
Root extracts showed inhibitory effects on Candida albicans and Aspergillus flavus [PMID:38474690]. Leaf extracts showed inhibitory effects on Pseudomonas aeruginosa and Staphylococcus aureus [PMID:38474690].
Evidence summary
PubMed sources
- 1.PMID: 7765756 (1994) — Triterpenoid saponins from Ardisia crenata. · Phytochemistry
- 2.PMID: 38999576 (2024) — Biochar Effectively Promoted Growth of Ardisia crenata by Affecting the Soil Physicochemical Properties. · Plants (Basel, Switzerland)
- 3.PMID: 35428421 (2023) — Two new phenol compounds from roots of Ardisia crenata. · Natural product research
- 4.PMID: 39557103 (2025) — Ardisia Crispae Radix et Rhizoma: A review of botany, traditional uses, phytochemistry, pharmacology, and toxicology. · Journal of ethnopharmacology
- 5.PMID: 38108118 (2024) — Anti-inflammatory activity of a new lactone isolated from the leaves of Ardisia crenata Sims.